Overview

Rasburicase in Tumor Lysis Syndrome

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether rasburicase is effective and safety in correcting hyperuricemia.
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Treatments:
Rasburicase